GL1X · GenesisL1 explorer

Research workbench

Crystal structure of TSN15 in apo form

Analyse Crystal structure of TSN15 in apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6NOI
Type
protein
Length
412 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TSN15
Ligands
PO4
Pockets
6 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 18% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATSN15protein20818% helix, 43% strand—
BTSN15protein20418% helix, 44% strand—

Ligands and binding sites

  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • PGE · Triethylene glycol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13000.770.8936PGE
23370.770.8735empty
33460.540.7441empty
4740.400.7926PO4
5660.340.7614empty

Interfaces

1 interface between chains.

  • A–B · 1874 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 modified (engineered).

Compared structures

  • 6NOI · Crystal structure of Tsn15 in apo form · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.